Crossref
Antibody targeting TSLP suppresses DSS-induced colitis and activation of the JAK2/STAT5 pathway in mice
European Cytokine Network · 2023
DOI: 10.1684/ecn.2023.0489 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Cytokine Network, 2023. Verfasst von Wei Zhuang und 1 weiteren Autor:innen. Hauptthemen laut MEDLINE: Colitis, Inflammatory Bowel Diseases. Die Arbeit wurde bisher 5-mal zitiert (Crossref).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
ColitisInflammatory Bowel DiseasesAnimalsMiceThymic Stromal LymphopoietinSTAT5 Transcription FactorJanus KinasesSTAT Transcription FactorsSignal TransductionCytokinesInflammation
Stichwörter der Autor:innen
JAK2/STAT5 pathwayinflammationinflammatory bowel diseasemucosal barrierthymic stromal lymphopoietin
Substanzen
Thymic Stromal LymphopoietinSTAT5 Transcription FactorJanus KinasesSTAT Transcription FactorsCytokines
Zitieren
APA
Zhuang, W., & Li, Z. (2023). Antibody targeting TSLP suppresses DSS-induced colitis and activation of the JAK2/STAT5 pathway in mice. European Cytokine Network. https://doi.org/10.1684/ecn.2023.0489
Vancouver
Zhuang W, Li Z. Antibody targeting TSLP suppresses DSS-induced colitis and activation of the JAK2/STAT5 pathway in mice. European Cytokine Network. 2023. doi:10.1684/ecn.2023.0489
BibTeX
@article{Zhuang2023,
author = {Zhuang, Wei and Li, Zhen},
title = {Antibody targeting TSLP suppresses DSS-induced colitis and activation of the JAK2/STAT5 pathway in mice},
journal = {European Cytokine Network},
year = {2023},
doi = {10.1684/ecn.2023.0489}
}
EUVIMED